Motif Bio PLC Holding(s) in Company (1935Q)
25 November 2016 - 10:32PM
UK Regulatory
TIDMMTFB
RNS Number : 1935Q
Motif Bio PLC
25 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Motif Bio plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
---------------------------------------------------------------- ------------------------------------------
2. Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
----------------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
----------------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
----------------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
----------------------------------------------------------------------------------------------------------
Other (please
specify): CHANGE IN NATURE : SHARES LOANED OUT
&
CHANGE TO THE NUMBER OF VOTING RIGHTS
IN ISSUE, FOLLOWING THE RECENT PUBLIC
OFFER
------------------------------------------------------------ --------------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
-------------------------------------------------------------- --------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
Available on Request 5,944*
BNY Norwich Union Nominees
Limited 99,767*
Chase (GA Group) Nominees
Limited 3,801,750*
State Street Nominees Limited
1,038,396*
*denotes direct interest
Chase (GA Group) Nominees
Limited 1,698,925
Chase Nominees Limited 329,800
-------------------------------------------------------------- --------------------------------------------
5. Date of the transaction 23 November 2016
and date on
which the threshold is crossed
or
reached: (v)
-------------------------------------------------------------- --------------------------------------------
6. Date on which issuer notified: 24 November 2016
-------------------------------------------------------------- --------------------------------------------
7. Threshold(s) that is/are
crossed or 4% to <3% change at Direct
reached: (vi, vii) Interest Level (Box 8A)
>5% to <5% change at Combined
Interest Level (Box 8A)
6% to 3% change at Direct
Interest Level (Box 8A & 8B)
and
>5% to <5% change at Combined
Interest Level (Box 8A & 8B)
-------------------------------------------------------------- --------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------------ ------------------------------ ----------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------------ ----------------- ----------- ------------- ----------------------- ------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------------ ----------------- ----------- ------------- ---------- ----------- ------- ---------
Ordinary
Shares
GB00BVVT4H71 8,939,785* 8,939,785* 6,974,582 4,945,857 2,028,725 2.74% 1.12%
----------------- ----------- ------------- ---------- ----------- ------- ---------
*Includes Right to Recall Loaned Shares (1,528,203)
--------------------------------------------------------------------------------------------------------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------ ----------------- -------------------------- ----------------------- ------------------
1,965,203*
RIGHT TO RECALL
LOANED SHARES N/A N/A *Direct interest 1.09%
------------------ ----------------- -------------------------- ----------------------- ------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
8,939,785 4.95%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
--------------------------------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited & Friends Provident
International Limited, with the following chain of controlled
undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Life Holdings UK Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Friends Life FPG Limited (wholly owned subsidiary of
Aviva Life Holdings UK Limited)
* Friends Life FPL Limited (wholly owned subsidiary of
Friends Life FPG Limited)
* Friends Life Limited (wholly owned subsidiary of
Friends Life FPL Limited)
* Friends Life and Pensions Limited (wholly owned
subsidiary of Friends Life Limited)
* Friends Provident International Limited (wholly owned
subsidiary of Friends Life and Pensions Limited)
Proxy Voting:
--------------------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
----------------------------------------------- -------------------------------------
11. Number of voting rights proxy
holder will cease
to hold:
----------------------------------------------- -------------------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
----------------------------------------------- -------------------------------------
13. Additional information: Figures are based on the
total number of voting rights
of 180,643,744 as per the
Company's 'Closing of Public
Offer' announcement of 23
November 2016.
----------------------------------------------- -------------------------------------
14. Contact name: Neil Whittaker, Aviva plc
----------------------------------------------- -------------------------------------
15. Contact telephone number: 01603 684420
----------------------------------------------- -------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFFLLTLEFIR
(END) Dow Jones Newswires
November 25, 2016 06:32 ET (11:32 GMT)
Motif Bio (LSE:MTFB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Motif Bio (LSE:MTFB)
Historical Stock Chart
From Apr 2023 to Apr 2024
